Everyone's Talking About the SpaceX IPO. Why I Think You Should Avoid It, and What to Buy Instead.

SpaceX is reportedly preparing a confidential IPO that could value the company at $1.75 trillion and raise $75 billion, implying an estimated 87x price-to-sales multiple on about $20 billion of 2026 revenue. The article argues that the valuation is extremely rich and warns retail investors about post-IPO downside, while suggesting space-themed ETFs such as ARKX, PPA, and XAR as lower-risk alternatives.

Analysis

The headline risk here is not the existence of a Space IPO; it is the signaling effect on the broader “space/defense + frontier tech” complex. A deal priced at a very rich multiple would likely pull forward retail enthusiasm into adjacent names first, but that enthusiasm is usually fleeting unless the company can demonstrate a path to converting monopoly-like infrastructure into durable cash flow. That makes the short-term winners more likely to be the listed proxy basket than any pre-IPO story stock, because ETF flows can absorb sentiment without requiring perfect underwriting discipline.

The second-order dynamic is valuation gravity on the public comps. If this deal clears at an extreme multiple, it effectively resets investor expectations for satellite broadband, launch services, autonomy, and defense-adjacent growth assets; the market may temporarily re-rate Rocket Lab, Planet, Archer, and even higher-quality industrial suppliers as “next in line” beneficiaries. But that can create a trap: if the IPO trades down post-lockup or on disclosure of margin mix, the same basket is vulnerable to a rapid sentiment unwind over 1-3 months, especially names whose narratives are still ahead of fundamentals.

The contrarian angle is that a very high private-market mark may be less about upside confidence and more about scarcity value in a capital-constrained listing window. If public markets are forced to underwrite this at launch, the better expression is not chasing the issuer but owning the picks-and-shovels with actual revenue visibility. The key question is whether the IPO expands the total addressable investor base for the theme or simply exhausts it; if it is the latter, the trade is likely a sell-the-news event rather than a durable rerating.

Key Decisions for Investors

• Long XAR or PPA vs. avoid chasing any post-IPO SpaceX proxy rally for the next 4-8 weeks; these baskets capture theme flow with lower single-name downside if the IPO gaps and fades.
• Pair trade: long GE / short PL into the first 30-60 days after listing if space sentiment heats up; GE offers industrial earnings support while PL is more exposed to narrative-driven multiple compression.
• Buy Rocket Lab (RKLB) only on pullbacks after the IPO buzz peaks; target a 2-3 month window where sentiment washout may create a better entry than front-running the theme.
• Use call spreads on ACHR or PL rather than outright longs for any event-driven momentum trade; the implied upside is meaningful, but dilution and post-hype vol crush make defined-risk structures superior.
• Fade any broad defense-space basket that rerates >10% on headline alone unless there is follow-through in disclosed order growth; the trade only works if the IPO validates commercial demand, not just brand value.